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osting by EAbstract The aim of the present study was to evaluate the cytotoxicity and antioxidant activity
of 5-(2,4-dimethylbenzyl)pyrrolidin-2-one (DMBPO) extracted from marine Streptomyces VITS-
VK5 spp. The strain was isolated from sediment samples collected at the Marakkanam coast
of Bay of Bengal, India. Systematic screening of isolates for anti-Aspergillus activity resulted in
the identiﬁcation of Streptomyces species designated as Streptomyces VITSVK5 spp. Bioactivity
guided extraction and puriﬁcation yielded a compound 5-(2,4-dimethylbenzyl)pyrrolidin-2-one
(DMBPO) and was tested for cytotoxicity and antioxidant activity. The structure of the extracted
compound was established by spectroscopic studies and identiﬁed as 5-(2,4-dimethylbenzyl)pyrr-
olidin-2-one (DMBPO). DMBPO exhibited cytotoxic activity on HEP 2 and Hep G2 cell lines
with the IC50 value of 2.8 lg/ml and 8.3 lg/ml, respectively, as compared to Vero cell line
(22.6). DMBPO showed the hemolytic EC50 value of 288 lg/ml on human erythrocytes. DMBPO
treatment showed fewer (31.7%) aberrations, gaps and chromatid breaks as compared to
untreated controls (27.8%) of human chromosomes. DMBPO also exhibited signiﬁcant
(44.13% at 5 lg/ml DMBPO) DPPH radical scavenging activity and total antioxidant activity
(50.10% at 5 lg/ml DMBPO). The results of this study showed that DMBPO is cytotoxic to can-
cer cells and possesses antioxidant property.
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lsevier1. Introduction
Over the past 75 years, natural product derived compounds
have led to the discovery of many drugs to treat numerous
human diseases (Grabley and Thiericke, 1999). Natural prod-
ucts are chemical compounds derived from living organisms
e.g. plants, animals and microorganisms. They can be deﬁned
as chemical compounds isolated or derived from organisms
as primary or secondary metabolites. By employing sophisti-
cated techniques under various screening programs, the rate
of discovery of natural compounds exceeded 1 million so
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biologically active compounds that have been extracted are
from microbes, 45% are produced by actinobacteria, 38%
by fungi and 17% by unicellular bacteria (Demain and
Sa´nchez, 2009). The oceans cover more than 70% of earth
surface and little is known about the microbial diversity of
marine sediments, which is an inexhaustible resource that
has not been fully exploited. Marine extremophiles serve as
valuable natural resource for novel products such as antibiot-
ics, antitumor agents and other therapeutic substances
(Amador et al., 2003). Microbial secondary metabolites have
been known as one of the immense reservoir of natural
chemical diversity with potent biological activity (Bush and
Macielag, 2000). Most bacterial secondary metabolites are
generated through a unique, multi-step biosynthetic process
with speciﬁc enzymes for each complex structure formation.
Their encoding genes are normally clustered within the gen-
ome of the organism and the precursors for the biosynthesis
are derived from primary metabolites. Marine actinomycetes
are potential providers of novel bioactive metabolites and
have been currently emerging as an important source for
natural products with unique chemical diversity. Members
of the class actinobacteria especially Streptomyces spp. have
long been recognized as proliﬁc sources of useful bioactive
metabolites, providing more than 85% of naturally occurring
antibiotics discovered to date and continuing as a rich source
of new bioactive metabolites (Berdy, 2005).
Actinomycetes represent one of the most studied and
exploited classes of bacteria for their ability to make a wide
range of biologically active metabolites (Ikeda et al., 2003).
The actinobacteria plays a very important role among the mar-
ine bacterial communities, because of its diversity and ability
to produce novel chemical compounds of high commercial
value (Hopwood, 2007; Amador et al., 2003). The compounds
isolated from marine Streptomyces, 2-allyoxyphenol and strep-
topyyrolidine have been reported to possess antioxidant and
no cytotoxic activity (Arumugam et al., 2010; Shin et al.,
2008). The studies on marine actinomycetes with respect to
antioxidant and cytotoxic activity are very limited in the
Indian sub-continent and most of the actinomycetes isolated
were yet to be screened for bioactive secondary metabolites.
Hence a study was carried out to extract the active compound
from marine Streptomyces VITSVK5 spp. and to study its
hemolytic activity on human red blood cells, cytotoxic effect
on normal and selected cancer cells, DPPH free radical
scavenging, and total antioxidant activity. In this study the
cytotoxicity and antioxidant activity of a novel compound
5-(2,4-dimethylbenzyl)pyrrolidin-2-one extracted from Strep-
tomyces VITSVK5 spp. was reported.2. Materials and methods
2.1. Strain
The strain Streptomyces VITSVK5 spp. was isolated from the
salt pans of Marrakanam coast of Bay of Bengal, India. The
strain was selectively isolated using Starch casein agar, ISP
No. 1 medium and the nutritional and cultural conditions
for the growth were optimized. Isolation and characterization
of the strain was previously reported (Saurav and Kannabiran,
2010).2.2. Extraction and puriﬁcation of the compound
Well grown slant culture of the potential isolate was used for
the preparation of seed culture. The seed culture was inoculated
in 50 ml medium containing the optimized production medium
prepared with sea water 50%, distilled water 50%, pH 8.2 and
incubated for 2 days in a rotary shaker (200 rpm) at 30 C. The
inoculums (10%) were transferred into 200 ml production
medium in 1 l Erlenmeyer ﬂasks and kept for fermentation
for a week. After fermentation, the broth was centrifuged at
4000 rpm for 10 min at 10 C and the supernatant was sepa-
rated and ﬁltered in 0.2 lm membrane ﬁlter. The supernatant
was extracted twice with n-butanol (400 ml) and washed with
500 ml water. After separation, the organic phase was dried
over Na2SO4 (anhydrous). The extract was then concentrated
in a rotary vacuum and lyophilized using a freeze drier
(Thermo, USA) at 5 C for 5 h. The crude extracts were stored
at20 C. The butanol layer was concentrated and the residual
suspension (750 mg) was chromatographed over silica gel col-
umn and eluted with chloroform:MeOH (10:0, 9.5:0.5, 9:1,
8.5:1.5, 8:2, 7.5:2.5, 7:3). The active fractions were collected,
concentrated and further separated by preparative TLC on sil-
ica gel with chloroform:MeOH (8:2) and the purity of the com-
pound was analyzed.
2.3. Structure elucidation
The UV spectra of the compound were measured using UV–
Visible spectrophotometer (Techcomp, Hong Kong). In order
to investigate the presence of various functional groups in bio-
active compound, the sample was lyophilized and mixed with
KBr (1:20; 0.02 g of sample with KBr at a ﬁnal weight of
0.4 g) and then grounded, desorbed at 60 C for 24 h and
pressed to obtain IR-transparent pellets. Infrared spectra of
the compound were obtained using a Fourier Transform Infra-
red Spectrometer (FT/IR-AVATAR 330). The spectra were
collected within a scanning range of 400–4000/cm. The
FT-IR was ﬁrst calibrated for background signal scanning
with a control sample of pure KBr, and then the experimental
sample was scanned. The spectra obtained was analyzed for
various functional groups.
The proton NMR (1H NMR) and carbon NMR (13C
NMR, V Bruker Avance III 500 MHz (AV 500)) spectra of
the compound were obtained by using a dimethyl sulfoxide
d6 (DMSO-d6) as solvent. It was further evaluated with
DEPT-135. It was further conﬁrmed by mass spectroscopy
(HR-MS, Jeol GCMATE II). The structure of the compound
was established with the help of spectral data obtained from
spectroscopic techniques. The 3D structure of the compound
was obtained by using chemdraw software (Ultra 8.0).
2.4. Assay of hemolytic activity
Hemolytic effect of the lead compound on human erythrocytes
was evaluated by using washed human erythrocytes (RBCs).
For the preparation of human erythrocytes the method of
Malagoli (2007) was followed. The human erythrocyte was
obtained from the peripheral blood (B+) of a healthy volun-
teer. The blood was used within 24 h after bleeding. The eryth-
rocyte fraction was washed thrice with saline and resuspended
in 10 ml PBS. The hemolytic activity of the compound was
tested as reported earlier under in vitro conditions in 96-well
Bioactivity of 5-(2,4-dimethylbenzyl)pyrrolidin-2-one 83plates. Each well received 100 ll of 0.85% NaCl solution
containing 10 mM CaCl2. The ﬁrst well that served as negative
control contained only water, and in the second well, 100 ll of
compound in different concentrations (5–500 lg/ml) was
added. The osmolarity of extract was adjusted with 10X PBS
to prevent osmotic lysis of erythrocytes. The last well served
as positive control containing 20 ll of 0.1% Triton X-100 in
0.85% saline. Then, each well received 100 ll of human eryth-
rocytes (2% suspension) in 0.85% saline containing 10 mM
CaCl2. After 2 h of incubation, the cell suspension was centri-
fuged and the absorbance of supernatant was obtained at
540 nm. The average value was calculated from triplicate assay.
2.5. Assay of cytotoxicity
The cytotoxicity of the DMBPO (0–25 lg/ml) was tested on
Vero (Greenmonkey kidney),HEP2 (laryngeal carcinoma cells)
and Hep G2 (Hepatocellular carcinoma) cell lines by MTT cell
proliferation assay. Cells were cultured routinely in 75 cm2
culture ﬂasks and maintained in RPMI 1640/DMEM
(Himedia/Gibco, Mumbai, India) medium supplemented with
10% FBS (v/v) and 100 mg/l streptomycin and 100 IU/ml pen-
icillin (Himedia, India), at 37 C in 5%carbon dioxide. Cell lines
were quantiﬁed (1 · 105 cells/well) as per user manual (Cell-
Quanti MTT assay kit, Bioassay systems, CA). Brieﬂy, the cells
were cultured (80 ml per well) in a clear bottom 96-well tissue
culture plate and incubated till conﬂuence. Test compounds
were added with cells and incubated for various time periods.
After incubation, 15 ml (per 80 ll cell culture) of CellQuanti-
MTTTM reagent was added per well and incubated for 4 h at
37 C. Then 100 ml of the solubilization solution was added
and kept in an orbital shaker for one hour at room temperature.
The optical density was measured at 570 nm for each well on a
multi well plate reader (Bio Rad). The test was carried out in
triplicates. The wells containing only culture medium or treated
with 0.1%ofDMSO served as control. The average of the blank
(controls) was determined and subtracted from the absorbance
values. The graph was plotted with cell viability against the time
period with various concentrations of the compound.
2.6. Assay of chromosomal aberrations
The effect of DMBPO on healthy human chromosome was
studied to evaluate chromosomal aberrations if any. A total
of 10 healthy volunteer donors who have no record of smoking
and any history of chemical or radiation exposure were
included in this study. Venous blood was drawn in sterile
condition. Tests were performed in triplicates by adding
0.6 ml of heparinized blood to 6 ml of RPMI 1640 medium
(Gibco, India), supplemented with 1.2 ml of fetal bovine serum
(Himedia, India), antibiotics (penicillin and streptomycin,
Himedia, India) lymphocytes were stimulated with 4% phyto-
hemagglutinin (Invitrogen, USA) and the cultures were incu-
bated at 37 C for 72 h. Varying concentration of DMBPO
(20–500 lg/ml) was added in G2 phase of the cell cycle. One
hour prior to harvest, 0.4 mg/ml of colchicine (Sigma–Aldrich,
USA) was added to arrest the cells at metaphase.
2.7. Slide scoring analysis
A total of 50 well-spread metaphases were scored for each
individual on coded slides. The metaphases were scored for achromosome number and for number and type of structural
chromosomal aberrations. Breaks (lesions in which there is a
clear misalignment) and gaps (an achromatic lesion in which
there is a minimal misalignment) were considered. In addition
other structural aberrations like dicentrics and ring chromo-
somes were also scored. The mitotic index (MI) was expressed
as the number of cells in the mitotic division stage per 1000
cells. Mean chromosomal aberrations per cell for each subject
was calculated and group mean values for patients and control
individuals were compared for a statistical signiﬁcance using
Student’s t-test.
2.8. Assay of DPPH scavenging activity
The DPPH free radical scavenging activity was determined by
the method of Madhumitha and Saral (2009) with some mod-
iﬁcations. Each sample at different concentration in ethanol
(2 ml) was mixed with 2 ml of ethanolic solution containing
1 mM DPPH. The mixture was shaken vigorously, and then
left to stand for 30 min in the dark. The absorbance was mea-
sured at 517 nm. The absorbance of the control was obtained
by replacing the sample with ethanol. DPPH radical scaveng-
ing activity of the sample was calculated as follows:
DPPH radical scavenging activity
¼ ½Abscontrol Abssample=Abs 1002.9. Assay of total antioxidant activity
The total antioxidant activity of DMBPO was determined
according to the method of Prieto et al., (1999). Brieﬂy,
0.3 ml of sample was mixed with 3.0 ml reagent solution
(0.6 M sulfuric acid, 28 mM sodium phosphate and 4 mM
ammonium molybdate). Reaction mixture was incubated at
95 C for 90 min under water bath. Absorbance of all the sam-
ple mixtures was measured at 695 nm. The total antioxidant
activity was expressed as the number of equivalents of ascorbic
acid.
2.10. Statistical analysis
All the experiments were performed in triplicates and the
data obtained were expressed as mean ± standard error.
P-values < 0.05 were considered as statistically signiﬁcant.
The IC50 and MIC50 values and their respective 95% conﬁ-
dence intervals were calculated by non-linear regression anal-
ysis using the data analysis software (Prism).3. Results and discussion
Microorganisms from extreme environments have gained con-
siderable attention in the recent years because of their diversity
and biological activities, mainly due to their ability to produce
novel chemical compounds of high commercial value. Micro-
bial sources serve as a template for the isolation of many
bioactive compounds. Streptomyces being the largest genus
of the actinomycetes; is exclusively important in the produc-
tion of pharmaceutically useful compounds including antibac-
terials antifungals, antitumor agents and immunosuppressants.
The process of bioactive guided extraction and puriﬁcation
resulted in the isolation of active compound from the culture
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Figure 2 Effect of DMBPO (50–500 lg/ml) on hemolysis of
human RBCs. Values of mean of three independent experiments
with standard error bar.
84 K. Saurav, K. Kannabiranbroth (10 l) of Streptomyces VITSVK5 spp. and the yield of
pure compound was 112.3 mg. The assessment of purity of
the compound by TLC and visualization of spot by iodine
reagent and sulfuric acid resulted in identiﬁcation of single
spot with Rf value of 0.43 (chloroform:methanol, 8:2). The
spectral data obtained for the compound were used to estab-
lish the structure of the compound. UV/vis (MeOH) kmax
290 nm; FT-IR cm1 3436 (–NH), 2928, 1729 (C‚O); 1H
NMR (DMSO-d6 500 MHz): 0.871 (s, J= 64 Hz, –CH3),
1.23–1.39 (m, J= 44 Hz, 2 · CH2), 3.37 (t, 1H), 4.29 (s, 2H),
7.25 (s, 1H), 7.65–7.69 (t, 2H), 8.17 (s, 1H); 13C NMR
(DMSO-d6 500 MHz): 13.80 (CH3), 18.60 (CH3),
34.65(2 · CH2), 60.34 (CH2), 64.98 (CH), 128.62, 131.4,
133.6, 134.3, 136.7, 144.7, 166.9. DEPT; HRMS; m/z (found/
cal.): 203.1325/203.1310. Based on the spectral data, the struc-
ture of the compound was identiﬁed as 5-(2,4-dimethylben-
zyl)pyrrolidin-2-one (DMBPO) and the molecular formula
was determined as C13H17NO. The structure of the compound
is illustrated in Fig. 1. It is soluble in methanol, chloroform
and DMSO. DMBPO showed signiﬁcant anti-Aspergillus
activity (unpublished data) against drug resistant Aspergillus
clinical isolates and in order to know its toxicity on human
cells the following studies were carried out.
3.1. Hemolytic activity
Hemolytic assay was performed to ascertain the effect of
DMBPO on membrane disruption. DMBPO exhibited a weak
membranolytic activity on erythrocyte membrane with EC50
value of 288 lg/ml (Fig. 2). The total hemolysis of erythrocytes
(positive control) was achieved with 20 ll of Triton X-100
(0.1%) after 1 h incubation. The EC50 and 95% conﬁdence
interval (CI 95%) were obtained by non-linear regression anal-
ysis. Evaluation of membrane stability during exposure of
newer drugs is important and that to erythrocytes represent
a good model for the study of membrane stability. The effect
of various bioactive compounds on mechanical stability of
the erythrocytic membrane serves as good indicator of mem-
brane stability. The results of the present study showed that
the DMBPO is non-hemolytic at low concentrations
(5–50 lg/ml).
3.2. Chromosomal aberrations
The effect of different concentrations of DMBPO on chromo-
somes was studied and it was observed that the most fre-
quently observed aberrations were gaps and chromatid
breaks in DMBPO (200 lg/ml) treated (31.7% total cells
scored) cells and as compared to control (27.8%). The meanNH
O
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Figure 1 Structure of 5-(2,4-dimethylbenzyl)pyrrolidin-2-one.frequency of aberrant cells was found to be signiﬁcantly low
(2.05±0.76) as compared to controls (1.69±0.71) at 200 lg/
ml where P> 0.01. The aberration was not increased up to
500 lg/ml of DMBPO. Induction of aberration by a DMBPO
in donors was found to be signiﬁcantly low as compared to the
normal control (Fig. 4). Cytogenetic analysis of chromosomal
aberrations has been suggested to be a useful tool to determine
the safe maximum allowable concentration (MAC) of any
drug (Sˇra´m, 1981). The MAC of a chemical is deﬁned as the
maximum concentration which does not have any adverse af-
fect on the human health on exposure. Chromosomal aberra-
tions in human peripheral lymphocytes are recognized as a
valuable biomarker to study the effect of the drug.
3.3. Cytotoxicity
The cytotoxic effect of different concentrations of DMBPO on
normal Vero cell lines, Hep G2 and HEP2 cell lines were eval-
uated by MTT assay in 96-well plates. This assay is often used
to measure viable cell where MTT (3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide, a yellow tetrazole) is
reduced to purple formazan in living cell. For determination
of IC50, cells were assessed for proliferation inhibition and
the IC50 values were calculated as 22.6, 8.3 and 2.8 lg/ml for
Vero, HepG2 and HEP2 cell lines, respectively (Fig. 3). No
morphological variations were observed in DMBPO treated
Vero cells. Different concentrations of DMBPO on the tested
cells revealed that DMBPO exhibits concentration and time
dependent inhibition. The observed IC50 value indicates that
DMBPO was less toxic to normal cells when compared to
the malignant cells. Streptopyrrolidine, a benzyl pyrrolidine
derivative isolated from a marine derived Streptomyces spp.
KORDI-3973 was reported to be an angiogenesis inhibitor
(Shin et al., 2008). Daryamides, antifungal polyketides isolated
from culture broth of a Streptomyces strain, CNQ-085 have
been shown to exhibit moderate cytotoxicity against the
human colon carcinoma cell line HCT-116 and moderate
antifungal activities against Candida albicans (Asolkar et al.,
2006). Similarly Chandrananimycins, isolated from marine
Actinomadura spp. MO48 have been shown to exhibit antibac-
terial, antifungal and anticancer activity (Maskey et al., 2003).
The assessment of cytotoxicity is very important and a crucial
step in the development of new therapeutic drugs for clinical
application.
0.0
78
0.1
56
0.3
12
5
0.6
25 1.2
5 2.5 5 10 20 25
0
50
100
150
Vero with DMBPO
Vero without DMBPO
HEP2
HEPG2
Concentration of DMBPO (µg/ml)
C
el
l v
ia
bi
lit
y 
(%
)
Figure 3 Effect of DMBPO on Vero, HepG2 and HEP2 cell
lines determined by MTT assay. Cells treated with DMBPO at
different concentration (0.078–25 lg/ml). Values are mean of three
independent experiments standard error bar was shown in the
ﬁgure.
Figure 4 Effect of DMBPO on human chromosomal aberra-
tions. (A) Metaphase spread for the untreated sample. (B)
Metaphase spread for the treated sample with DMBPO at
200 lg/ml and arrow indicating chromosomal gap.
5 10 20 30 40 50
0
20
40
60
80
100
DPPH scavenging activity
Total antioxidant activity
Abscorbic Acid
Concentration of DMBPO (µg/ml)
Ac
tiv
ity
 (%
)
Figure 5 DPPH scavenging and total antioxidant activity of
different concentration of DMBPO and was compared with
control as Ascorbic acid. Values are mean standard error of three
independent experiments.
Bioactivity of 5-(2,4-dimethylbenzyl)pyrrolidin-2-one 853.4. Antioxidant activity
DPPH radical scavenging and total antioxidant activity of
DMBPO was compared with ascorbic acid as control and
are given in Fig. 5. The radical scavenging activity of DMBPO
was concentration dependent and gradual increase of
concentration increased the activity. At 5 lg/ml, this activity
was 44.13% and at 10 lg/ml, the activity was increased to57.83%. Total antioxidant activity was also concentration
dependent. It was 50.10% (5 lg/ml) and 59.32% at 10 lg/ml
of DMBPO concentration. Our results are in accordance with
the report of Kumaqai et al. (1993), a compound PC-766 B iso-
lated from marine actinomycetes Nocardia brasiliensis exhib-
ited dose dependent antioxidant activity. Takamatsu et al.
(2003) reported a Cymopo and avrainvilleol a meromonoter-
pene compound isolated from marine sponges exhibited anti-
oxidant activity with the IC50 value of 4.0–6.1 lM. A
superoxide scavenging inhibition and H2O2 induced DNA
strand scission protection was observed with the compound
strobilin–felixinin, sesterterpene isolated from marine sponges
(Jiang et al., 2004).
The DPPH method is based on the reduction of DPPH, a
stable free radical. With the odd electron, the free radical
DPPH gives a maximum absorption at 517 nm by visible spec-
troscopy (purple color). As the odd electron of the radical
becomes paired off in the presence of a hydrogen donor,
e.g., a free radical scavenging antioxidant, the absorption
strength is decreased, and the resulting decolorization (yellow
color) is stoichiometric with respect to the number of electrons
captured (Blois, 1958). This reaction has been widely used to
investigate the free radical scavenging ability of pure com-
pounds or act as hydrogen donors.
In conclusion the active compound DMBPO isolated from
Streptomyces VITSVK5 spp. is less toxic to cells and possess
antioxidant property which could be studied further by
in vivo animal model studies.Acknowledgment
Authors thank the management of VIT University for provid-
ing facilities to carry out this study.
References
Amador, M.L., Jimeno, J., Ares, L.P., Funes, H.C., Hidalgo, M., 2003.
Progress in the development and acquisition of anticancer agents
from marine sources. Ann. Oncol. 14, 1607–1615.
86 K. Saurav, K. KannabiranArumugam, M., Mitra, A., Jaisankar, P., Dasgupta, S., Sen, T.,
Gachhui, R., Mukhopadhyay, U.K., Mukherjee, J., 2010. Isolation
of an unusual metabolite 2-allyloxyphenol from a marine actino-
bacterium, its biological activities and applications. Appl. Micro-
biol. Biotechnol. 86, 109–117.
Asolkar, R.N., Jensen, P.R., Kauffman, C.A., Fenical, W., 2006.
Daryamides A-C weakly cytotoxic polyketides from a marine
derived actinomycete of the genus Streptomyces strain CNQ-085. J.
Nat. Prod. 69, 1756–1759.
Berdy, J., 2005. Bioactive microbial metabolites. A personal view. J.
Antibiot. 58, 1–26.
Blois, M.S., 1958. Antioxidant determinations by the use of a stable
free radical. Nature 26, 1199–1200.
Bush, K., Macielag, M., 2000. New approaches in the treatment of
bacterial infections. Curr. Opin. Chem. Biol. 4, 433–439.
Demain, A.L., Sa´nchez, S., 2009. Microbial drug discovery: 80 years of
progress. J. Antibiot. 62, 5–16.
Grabley, S., Thiericke, R., 1999. The impact of natural products on
drug discovery. In: Grabley, S., Thiericke, R. (Eds.), Drugs
Discovery from Nature. Springer-Verlag, Berlin, pp. 1–37.
Hopwood, D.A., 2007. Therapeutic treasures from the deep. Nature
Chem. Biol. 3, 457–458.
Ikeda, H., Ishikawa, J., Hanamato, A., Shinose, M., Kikuchi, H.,
Shiba, T., Sakaki, Y., Hattori, H., Omura, S., 2003. Complete
genome sequence and comparative analysis of the industrial
microorganism Stretomyces avermitilis. Nat. Biotechnol. 21, 526–
531.
Jiang, Y.H., Ryu, S.H., Ahn, E.Y., You, S., Lee, B.J., Jung, J.H., Kim,
D.K., 2004. Antioxidant activity of (8E,13Z, 20Z)-strobilinin/
(7E,13Z, 20Z)-felixinin from a marine sponge Psammocinia sp.
Nat. Prod. Sci. 10, 272–276.
Kumaqai, K., Fukui, A., Tanaka, S., Ikemoto, M., Moriquchi, K.,
Nabeshima, S., 1993. PC-766B, a new macrolide antibiotic
produced by Nocardia brasiliensis II. Isolation, physico-chemicalproperties and structures elucidation. J Antibiot. (Tokyo) 46, 1139–
1144.
Madhumitha, G., Saral, A.M., 2009. Free radical scavenging assay of
Thevetia neriifolia leaf extracts 21, 2468–2470.
Maskey, R.P., Li, F.C.S., Qin, H.H., Fiebig, Laatsch, H., 2003.
Chandrananimycins A–C: production of novel anticancer antibi-
otics from a marine Actinomadura spp. isolate M048 by variation of
medium composition and growth conditions. J. Antibiot. 56, 622–
629.
Malagoli, D., 2007. A full-length protocol to test hemolytic activity of
palytoxin on human erythrocytes. Invert. Surviv. J. 4, 92–94.
Pimentel-Elardo, S.M., Kozytska, S., Bugni, T.S., Ireland, C.M., Moll,
H., Hentsche, U., 2010. Anti-parasitic compounds from Strepto-
myces spp. strains isolated from Mediterranean sponges. Mar.
Drugs 8, 373–380.
Prieto, P., Pineda, M., Aguilar, M., 1999. Spectrophotometric quan-
titation of antioxidant capacity through the formation of a
phosphomolybdenum complex: speciﬁc application to the determi-
nation of vitamin E. Anal. Biochem. 269, 337–341.
Saurav, K., Kannabiran, K., 2010. Antifungal activity of Streptomyces
VITSVK5 spp. against drug resistant Aspergillus clinical isolates
from pulmonary tuberculosis patients. J. Mycol. Med. 20, 101–107.
Shin, H.J., Kim, T.S., Lee, H-S., Park, J.Y., Choi, I-K., Kwon, H.J.,
2008. Streptopyrrolidine, an angiogenesis inhibitor from a marine-
derived Streptomyces spp. KORDI-3973. Phytochemistry 69, 2363–
2366.
Sˇra´m, R.J., 1981. Cytogenetic analysis of peripheral lymphocytes as a
method for monitoring environmental levels of mutagens. In: Gut,
I., Cikrt, M., Plaa, G.L. (Eds.), Industrial and Environmental
Xenobiotics: Metabolism and Pharmacokinetics of Organic Chem-
icals and Methods. Springer-Verlag, Berlin, pp. 187–193.
Takamatsu, S., Hodges, T.W., Rajbhandari, I., Gerwick, W.H.,
Hamann, M.T., Nagle, D.G., 2003. Marine natural products as
novel antioxidant prototypes. J. Nat. Prod. 66, 605–608.
